Evaluation of the Effectiveness of Thrombolytic Therapy in Acute Ischemic Stroke Patients Using NIRS

NCT03621917 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2018-10-26

No results posted yet for this study

Summary

Investigators aim to study effectiveness of systemic thrombolytic therapy on acute ischemic stroke patients with near infrared spectroscopy.

Conditions

  • Acute Stroke
  • Thrombolytic Therapy
  • Stroke, Ischemic

Interventions

DEVICE

Near-infrared spectroscopy reading

Non-invasive readings will be taken from forehead with near-infrared spectroscopy

Sponsors & Collaborators

  • Dokuz Eylul University

    lead OTHER

Principal Investigators

  • Nese Colak Oray, MD

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2018-10-01
Completion
2018-10-01
FDA Device
Yes

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03621917 on ClinicalTrials.gov